{"title":"何时以及如何告知患者临床医生或组织将临床实践出售给私募股权买家?","authors":"Cheryl Erwin, Sheryl Tatar Dacso","doi":"10.1001/amajethics.2025.318","DOIUrl":null,"url":null,"abstract":"<p><p>Private equity (PE) firms' acquisition and management of health service delivery entities, such as specialty physicians' practices, have been associated with increased cost and diminished quality of care. This commentary on a case argues that clinician-sellers have obligations to disclose to their patients known and foreseeable changes-especially those affecting services' cost or quality or health outcomes-to which PE ownership could contribute.</p>","PeriodicalId":38034,"journal":{"name":"AMA journal of ethics","volume":"27 5","pages":"E318-324"},"PeriodicalIF":0.0000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"When and How Should Patients Be Informed About Clinicians' or Organizations' Sale of a Clinical Practice to a Private Equity Buyer?\",\"authors\":\"Cheryl Erwin, Sheryl Tatar Dacso\",\"doi\":\"10.1001/amajethics.2025.318\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Private equity (PE) firms' acquisition and management of health service delivery entities, such as specialty physicians' practices, have been associated with increased cost and diminished quality of care. This commentary on a case argues that clinician-sellers have obligations to disclose to their patients known and foreseeable changes-especially those affecting services' cost or quality or health outcomes-to which PE ownership could contribute.</p>\",\"PeriodicalId\":38034,\"journal\":{\"name\":\"AMA journal of ethics\",\"volume\":\"27 5\",\"pages\":\"E318-324\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"AMA journal of ethics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1001/amajethics.2025.318\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Social Sciences\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"AMA journal of ethics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1001/amajethics.2025.318","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Social Sciences","Score":null,"Total":0}
When and How Should Patients Be Informed About Clinicians' or Organizations' Sale of a Clinical Practice to a Private Equity Buyer?
Private equity (PE) firms' acquisition and management of health service delivery entities, such as specialty physicians' practices, have been associated with increased cost and diminished quality of care. This commentary on a case argues that clinician-sellers have obligations to disclose to their patients known and foreseeable changes-especially those affecting services' cost or quality or health outcomes-to which PE ownership could contribute.
期刊介绍:
The AMA Journal of Ethics exists to help medical students, physicians and all health care professionals navigate ethical decisions in service to patients and society. The journal publishes cases and expert commentary, medical education articles, policy discussions, peer-reviewed articles for journal-based and audio CME, visuals, and more. Since its inception as an editorially-independent journal, we promote ethics inquiry as a public good.